SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-007600
Filing Date
2012-08-02
Accepted
2012-08-02 16:03:42
Documents
14
Period of Report
2012-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdl_8k-080212.htm 8-K 37820
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 180382
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 7375
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 39510
5 EXHIBIT 99.4 ex99-4.htm EX-99.4 352567
6 logo.jpg GRAPHIC 4549
7 b1.jpg GRAPHIC 214824
8 b2.jpg GRAPHIC 306642
9 b3.jpg GRAPHIC 187023
10 b4.jpg GRAPHIC 203573
11 b5.jpg GRAPHIC 157645
12 b6.jpg GRAPHIC 159751
13 b7.jpg GRAPHIC 160627
14 b8.jpg GRAPHIC 186894
  Complete submission text file 0001437749-12-007600.txt   2798881
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 121003452
SIC: 2836 Biological Products, (No Diagnostic Substances)